Investigations on the pharmacokinetics of trofosfamide and its metabolites: first report of 4-hydroxy-trofosfamide kinetics in humansPREISS, Rainer; BAUMANN, Frank; STEFANOVIC, Dragan et al.Cancer chemotherapy and pharmacology. 2004, Vol 53, Num 6, pp 496-502, issn 0344-5704, 7 p.Article

Design of new oxazaphosphorine anticancer drugsJUN LIANG; MIN HUANG; WEI DUAN et al.Current pharmaceutical design. 2007, Vol 13, Num 9, pp 963-978, issn 1381-6128, 16 p.Article

QUANTITATIVE BESTIMMUNG VON CYCLOPHOSPHAMID, IFOSFAMID UND TROFOSFAMID SOWIE IHRER STABILEN METABOLITE AUF DER DC-PLATTE MIT 4-PYRIDINALDEHYD-2-BENZOTHIAZOLYLHYDRAZON (PBH). = DOSAGE DU CYCLOPHOSPHAMIDE, DE L'IPHOSPHAMIDE ET DU TROPHOSPHAMIDE ET DE LEURS METABOLITES STABLES PAR CHROMATOGRAPHIE SUR COUCHE MINCE AU MOYEN DE PBH (PYRIDINE-4 ALDEHYDE BENZOTHIAZOLYL-2 HYDRAZONE)NORPOTH K; ADDICKS HW; WITTING U et al.1975; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1975; VOL. 25; NO 9; PP. 1331-1336; ABS. ANGL.; BIBL. 20 REF.Article

Pharmacokinetics and efficacy of ifosfamide or trofosfamide in patients with intraocular lymphomaJAHNKE, K; WAGNER, T; BECHRAKIS, N. E et al.Annals of oncology. 2005, Vol 16, Num 12, pp 1974-1978, issn 0923-7534, 5 p.Article

COMPARISON OF THE GENETIC ACTIVITY OF CYCLOPHOSPHAMIDE, IFOSFAMIDE AND TROFOSFAMIDE IN HOST-MEDIATED ASSAYS WITH THE GENE CONVERSION SYSTEM OF YEAST = COMPARAISON DE L'ACTIVITE GENETIQUE DU CYCLOPHOSPHAMIDE, DE L'IFOSFAMIDE ET DU TROFOSFAMIDE DANS LES DOSAGES A HOTE INTERMEDIAIRE AVEC LE SYSTEME DE CONVERSION GENIQUE DES LEVURESSIEBERT D.1974; Z. KREBSFORSCH. KLIN. ONKOL.; DTSCH.; DA. 1974; VOL. 81; NO 3-4; PP. 261-267; ABS. ALLEM.; BIBL. 1P.Article

Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racematesKUSNIERCZYK, H; RADZIKOWSKI, C; PAPROCKA, M et al.Journal of immunopharmacology. 1986, Vol 8, Num 4, pp 455-480, issn 0163-0571Article

¹⁴N NUCLEAR QUADRUPOLE RESONANCE IN CARCINOSTATIC PHOSPHAMIDESGREENBAUM SG; BRAY PJ.1980; PHYS. LETT. SECT. A; ISSN 0375-9601; NLD; DA. 1980; VOL. 75; NO 5; PP. 438-440; BIBL. 20 REF.Article

Metronomic trofosfamide inhibits progression of human lung cancer xenografts by exerting anti-angiogenic effectsKLINK, T; BELA, C; STOELTING, S et al.Journal of cancer research and clinical oncology. 2006, Vol 132, Num 10, pp 643-652, issn 0171-5216, 10 p.Article

Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomasHARTMANN, J. T; OECHSLE, K; MAYER, F et al.Anticancer research. 2003, Vol 23, Num 2C, pp 1899-1901, issn 0250-7005, 3 p.Article

DETOXIFICATION OF UROTOXIC OXAZAPHOSPHORINES BY SULFHYDRYL COMPOUNDSBROCK N; POHL J; STEKAR J et al.1981; Z. KREBSFORSCH. KLIN. ONKOL.; ISSN 0084-5353; DEU; DA. 1981; VOL. 100; NO 3; PP. 311-320; BIBL. 21 REF.Article

IXOTEN-THERAPIE BEI MALIGNEN LYMPHOMEN = TRAITEMENT DES LYMPHOMES MALINS PAR L'IXOTENPOETZI P; AIGINGER P; KUEHBOECK J et al.1979; ACTA MED. AUSTRIACA; ISSN 0303-8173; AUT; DA. 1979; VOL. 6; NO 5; PP. 247-249; ABS. ENG; BIBL. 4 REF.Article

ETUDE COMPAREE DE L'ACTIVITE ANTIMITOTIQUE DU CYCLOPHOSPHAMIDE, DU TROFOSFAMIDE ET DE L'IFOSFAMIDE SUR LA CELLULE MERISTEMATIQUE VEGETALE ET SUR LA CELLULE ANIMALE EN CULTURE IN VITRODEYSSON G; ADOLPHE M; SEMONT H et al.1981; C.R. SOC. BIOL. FIL.; ISSN 0037-9026; FRA; DA. 1981; VOL. 175; NO 2; PP. 177-181; ABS. ENG; BIBL. 8 REF.Article

Palliative chemotherapy in non-Hodgkin's lymphomaSALMINEN, E; NIKKANEN, V; LINDHOLM, L et al.Oncology. 1997, Vol 54, Num 2, pp 108-111, issn 0030-2414Article

Chromatographic resolutions. XIV: Optical resolution of the racemic anticancer drug ifosfamide and other chiral oxazaphosphorinesBLASCHKE, G; MAIBAUM, J.Journal of chromatography. 1986, Vol 366, pp 329-334, issn 0021-9673Article

IN-VITRO-REAKTION DER DREI ALKYLIERENDEN PHARMAKA CYCLOPHOSPHAMID IFOSFAMID UND TROFOSFAMID MIT DNS UND DNS-BAUSTEINEN = LA REACTION IN VITRO DES 3 MEDICAMENTS ALKYLANTS: CYCLOPHOSPHAMIDE, IFOSFAMIDE ET TROFOSFAMIDE AVEC L'ADN ET LES CONSTITUANTS DE L'ADNLINDEMANN H; HARBERS E.1980; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1980; VOL. 30; NO 12; PP. 2075-2080; ABS. ENG; BIBL. 29 REF.Article

ANTIDOT GEGEN UROTOXISCHE WIRKUNGEN DER OXAZAPHOSPHORIN-DERIVATE CYCLOPHOSPHAMID, IFOSFAMID UND TROFOSFAMID = UN ANTIDOTE CONTRE LES ACTIVITES UROTOXIQUES DES DERIVES OXAZAPHOSPHORINES: CYCLOPHOSPHAMIDE, IFOSFAMIDE ET TROFOSFAMIDEBROCK N; STEKAR J; POHL J et al.1979; NATURWISSENSCHAFTEN; DEU; DA. 1979; VOL. 66; NO 1; PP. 60-61; BIBL. 11 REF.Article

CYCLOPHOSPHAMID UND HARNBLASENKARZINOM. = CYCLOPHOSPHAMIDE ET TUMEURS VESICALESPETRI E; ALTWEIN JE.1978; DTSCHE MED. WSCHR.; DTSCH.; DA. 1978; VOL. 103; NO 1; PP. 30-32; ABS. ANGL.; BIBL. 38 REF.Article

GENETIC EFFECTS OF CYCLOPHOSPHAMIDE, IFOSFAMIDE AND TROCFOSFAMIDE.MOHN GR; ELLENBERGER J.1976; MUTATION RES.; NETHERL.; DA. 1976; VOL. 32; NO 3-4; PP. 331-360; BIBL. 6 P.Article

ZYTOSTATISCHE TUMORTHERAPIE UNTER TEILSYNCHRONISATIONSBEDINGUNGEN. = TRAITEMENT CYTOSTATIQUE DES TUMEURS DANS DES CONDITIONS DE SYNCHRONISATION PARTIELLEKOERNER F; LUND S; JONAS U et al.1975; MUENCH. MED. WSCHR.; DTSCH.; DA. 1975; VOL. 117; NO 34; PP. 1345-1348; ABS. ANGL.; BIBL. 18 REF.Article

Verlaufsstabilisierung von Patienten mit fortgeschrittenen malignen Melanomen in Stadium IV durch Trofosfamidbehandlung = Amelioration of disease progression in advanced stage IV malignant melanoma with trofostamideENK, A. H; KNOP, J.Hautarzt. 2000, Vol 51, Num 7, pp 486-489, issn 0017-8470Article

Investigation of the major human hepatic cytochrome P450 involved in 4-hydroxylation and N-dechloroethylation of trofosfamideMAY-MANKE, A; KROEMER, H; HEMPEL, G et al.Cancer chemotherapy and pharmacology. 1999, Vol 44, Num 4, pp 327-334, issn 0344-5704Article

Trofosfamide in patients with pancreatic cancerSCHMIDT-SANDTE, W; DAGEFÖRDE, J; KLAPDOR, R et al.Anticancer research. 1999, Vol 19, Num 4A, pp 2485-2487, issn 0250-7005Conference Paper

Trofosfamide as a salvage treatment with low toxicity in malignant lymphoma. A phase II studyHELSING, M. D.European journal of cancer (1990). 1997, Vol 33, Num 3, pp 500-502, issn 0959-8049Article

ETUDE COMPARATIVE DE LA CYTOTOXICITE DU CYCLOPHOSPHAMIDE, DE L'IFOSFAMIDE, DU TROFOSFAMIDE ET DES PRINCIPAUX METABOLITES DU CYCLOPHOSPHAMIDE SUR DIFFERENTS MODELES CELLULAIRES EN CULTURESEMONT H.1980; ; FRA; DA. 1980; 41; 190 P.: ILL.-6 PL.; 30 CM; BIBL. 95 REF.; TH.: PHARM./PARIS 5/1980Thesis

THE CRYSTAL AND MOLECULAR STRUCTURE OF TROFOSFAMIDE (3-(2-CHLOROETHYL)-2-(BIS(2-CHLOROETHYL) AMINO) PERHYDRO-2H-1,3,2-OXAZAPHOSPHORINE 2-OXIDE, C₉H₁₈CL₃N₂O₂P).PERALES A; GARCIA BLANCO S.1977; ACTA CRYSTALLOGR., B; DANEM.; DA. 1977; VOL. 33; NO 6; PP. 1939-1943; BIBL. 8 REF.Article